1. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
   Mehrdokht Sadrkhanloo et al, 2023, Pathology - Research and Practice CrossRef
2. Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies
   Hong Wang et al, 2021, Journal of Nanobiotechnology CrossRef
3. Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer
   Zong Hou et al, 2022, Journal of Ethnopharmacology CrossRef
4. A systematic exploration of ginsenoside Rg5 reveals anti-inflammatory functions in airway mucosa cells
   Hyojin Heo et al, 2023, Journal of Ginseng Research CrossRef
5. An innovative processing driven efficient transformation of rare ginsenosides enhances anti-platelet aggregation potency of notoginseng by integrated analyses of processing-(chemical) profiling-pharmacodynamics
   Wenxiang Fan et al, 2024, Journal of Ethnopharmacology CrossRef
6. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway
   Caidie Zhang et al, 2024, Human & Experimental Toxicology CrossRef
7. Ginsenoside Rg5: A Review of Anticancer and Neuroprotection with Network Pharmacology Approach
   Xu-Fei Gao et al, 2022, The American Journal of Chinese Medicine CrossRef
8. Ginsenoside Rg5 as an anticancer drug: a comprehensive review on mechanisms, structure–activity relationship, and prospects for clinical advancement
   Tilal Elsaman et al, 2024, Pharmacological Reports CrossRef
9. Ginsenoside Rk1 inhibits HeLa cell proliferation through an endoplasmic reticulum signaling pathway
   Qiuyang Li et al, 2023, Journal of Ginseng Research CrossRef
10. Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations
    Alexander Panossian et al, 2021, Pharmaceuticals CrossRef